News

Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, today announced that ...
The latest Auditor General's Report has once again raised flagrant breaches of Public Finance Management regulations, revealing that, as of June 2025, a staggering sum exceeding half a billion United ...